Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionAE Wealth Management LLC
Latest Disclosed Ownership6,681 shares
Latest Disclosed Value $ 5,163,849
AE Wealth Management LLC reports 22.05% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On May 13, 2026 - AE Wealth Management LLC filed a 13F-HR form disclosing ownership of 6,681 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $5,163,849 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 5,474 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 22.05% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,681 1,207 22.05 5,164 22.20 0.0008
2026-01-26 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 5,474 1,470 36.71 4,226 87.61 0.0243
2025-11-03 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,004 1,371 52.07 2,252 62.83 0.0144
2025-08-06 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,633 408 18.34 1,383 -1.98 0.0101
2025-05-06 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,225 445 25.00 1,412 11.28 0.0119
2025-02-13 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,780 706 65.74 1,268 12.31 0.0108
2024-11-14 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,074 527 96.34 1,130 96.69 0.0102
2024-08-12 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 547 89 19.43 575 30.45 0.0058
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 458 -3,210 -87.51 441 -87.24 0.0050
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,668 2,450 201.15 3,448 244.11 0.0176
2023-10-11 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,218 -2,031 -62.51 1,002 -57.07 0.0060
2023-07-10 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,249 -631 -16.26 2,335 -26.76 0.0140
2023-04-14 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,880 -677 -14.86 3,188 -3.04 0.0205
2023-01-31 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,557 -8,384 -64.79 3,288 -63.13 0.0238
2022-10-25 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 12,941 82 0.64 8,914 17.27 0.0707
2022-08-03 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 12,859 2,845 28.41 7,601 8.68 0.0608
2022-04-18 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10,014 176 1.79 6,994 12.57 0.0480
2022-01-20 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,838 5,658 135.36 6,213 145.57 0.0433
2021-11-01 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,180 -169 -3.89 2,530 4.16 0.0208
2021-07-21 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 4,349 601 16.04 2,429 37.00 0.0212
2021-04-27 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,748 3,044 432.39 1,773 421.47 0.0179
2021-02-01 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 704 -1,436 -67.10 340 -71.62 0.0039
2020-11-06 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,140 236 12.39 1,198 0.93 0.0171
2020-08-05 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,904 514 36.98 1,187 74.82 0.0183
2020-05-07 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,390 808 138.83 679 210.05 0.0156
2020-01-15 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 582 582 219 0.0048
2019-11-05 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -705 -100.00 0 -100.00
2019-07-22 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 705 705 221 0.0066
2018-05-14 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -548 -100.00 0 -100.00
2018-02-06 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 548 548 206 0.0182
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.